As early and effective antiretroviral therapy has become more widespread, HIV has
transitioned from a progressive, fatal disease to a chronic, manageable disease marked by …

HIV-related cardiovascular disease research is predominantly from Europe and North
America. Of the estimated 37· 9 million people living with HIV worldwide, 25· 6 million live in …

Stroke is a heterogeneous disease in persons living with human immunodeficiency virus
(HIV). HIV is thought to increase the risk of stroke through both HIV-related and traditional …

Background Stroke has relevant morbidity and mortality despite appropriate treatments and
early diagnosis. Beside common risk factors such as diabetes and atrial fibrillation …

Although retroviral therapy (ART) has changed the HIV infection from a fatal event to a
chronic disease, treated HIV patients demonstrate high prevalence of HIV associated …

Objective The stroke risk for persons living with human immunodeficiency virus (PLHIVs)
doubled compared to uninfected individuals. Stroke‐unit (SU)—access, acute reperfusion …

Alteplase is the main pharmacological treatment available for intravenous thrombolysis in
patients with acute ischemic stroke. Endovascular treatment alone or add-on to intravenous …

Introduction The global incidence of ischemic stroke among patients with human
immunodeficiency virus is increasing. The aim of this controlled case analysis was to study …

We present a case of haemorrhagic stroke secondary to longstanding Human
Immunodeficiency Virus infection and hypertension. We describe the clinical presentation of …

Background Human immunodeficiency virus (HIV) infection has been recognized as a risk
factor for both ischemic and hemorrhagic stroke among young adults. However, information …